Mechanism of action
Permethrin is a synthetic pyrethroid derived from natural pyrethrins found in chrysanthemum flowers. It acts by binding to voltage-gated sodium channels in the nerve cell membranes of arthropods, prolonging sodium channel activation and causing depolarization blockade. This results in repetitive nerve firing, paralysis, and eventual death of the parasite.
The drug is highly selective for arthropod sodium channels over mammalian channels, providing a favorable safety profile. Permethrin also delays the closure of sodium channels, leading to continuous nerve stimulation. Additionally, it disrupts potassium and chloride ion channels in arthropod cells, further contributing to neurotoxicity in the parasite.
Permethrin exhibits minimal systemic absorption through intact skin, which limits systemic toxicity. It is rapidly metabolized by ester hydrolysis when absorbed, primarily by hepatic esterases.
- Permethrin 5% cream is first-line therapy for scabies; apply neck-down for 8-14 hours
- Permethrin disrupts sodium channels in arthropod nerves, causing paralysis and death
- Pruritus may persist 2-4 weeks post-treatment due to hypersensitivity to dead mites, not treatment failure
- Second application at 7-14 days is recommended to kill newly hatched mites from surviving eggs
- Minimal systemic absorption (less than 2%) results in low toxicity and few drug interactions
- Permethrin is FDA Pregnancy Category B and preferred over lindane in pregnancy
- Treat all household contacts simultaneously to prevent re-infestation with scabies
- Permethrin 1% is used for head lice and pubic lice; 5% concentration for scabies
Indications
Permethrin is FDA-approved for the following conditions:
- Scabies (caused by Sarcoptes scabiei): 5% permethrin cream is first-line therapy
- Pediculosis capitis (head lice): 1% permethrin lotion or cream rinse
- Pediculosis pubis (pubic lice, "crabs"): 1% permethrin lotion
Off-label uses
- Prevention of lice infestation in epidemic settings
- Treatment of lice resistant to other pediculicides
- Prophylaxis for close contacts of scabies patients
- Impregnation of clothing for tick and mosquito bite prevention
For scabies, permethrin is preferred over lindane due to superior efficacy and safety profile. It is effective against all stages of lice and mites, including eggs (nits), though a second application is often recommended to eliminate newly hatched parasites.
Pharmacokinetics
Absorption: Permethrin has minimal dermal absorption through intact human skin, with less than 2% of the applied dose entering systemic circulation. Absorption may be slightly increased through inflamed or excoriated skin, which is common in scabies infestations.
Distribution: When absorbed, permethrin distributes into tissues but does not significantly accumulate due to rapid metabolism.
Metabolism: Permethrin is rapidly metabolized by ester hydrolysis in the skin and liver. Hepatic esterases cleave the ester linkage, producing inactive metabolites. This rapid first-pass metabolism contributes to low systemic toxicity.
Elimination: Metabolites are primarily excreted in urine, with small amounts in feces. The elimination half-life of absorbed permethrin is short, typically less than 24 hours. Complete elimination of metabolites occurs within a few days of application.
Special populations: Pharmacokinetic data in pediatric and elderly populations are limited, but the minimal systemic absorption suggests similar profiles across age groups.
Adverse effects
Permethrin is generally well tolerated with primarily local adverse effects.
Common adverse effects
- Skin irritation: burning, stinging, tingling at application site
- Pruritus: itching may persist or worsen temporarily after treatment (due to inflammatory response to dead mites, not treatment failure)
- Erythema: mild redness at application site
- Rash: maculopapular eruptions
- Dry skin and mild desquamation
Less common adverse effects
- Numbness or paresthesia at application site
- Scalp discomfort or edema
- Contact dermatitis (rare)
- Allergic reactions (uncommon)
Serious adverse effects
Systemic toxicity is rare due to minimal absorption. Case reports of accidental ingestion have described nausea, vomiting, abdominal pain, and CNS effects (tremor, seizures) at high doses.
Important clinical note: Pruritus may persist for 2-4 weeks after successful scabies treatment due to delayed hypersensitivity reaction to dead mite antigens. This does not indicate treatment failure and should not prompt immediate re-treatment.
Contraindications and warnings
Absolute contraindications
- Hypersensitivity to permethrin, pyrethrins, pyrethroid compounds, or chrysanthemums
- Hypersensitivity to any component of the formulation
Warnings and precautions
Pregnancy: Permethrin is FDA Pregnancy Category B. Animal studies show no fetal harm, and minimal systemic absorption suggests low risk. It is considered safe for use during pregnancy and is preferred over lindane.
Lactation: Minimal amounts are excreted in breast milk due to low systemic absorption. Breastfeeding is generally considered safe after permethrin application, though some experts recommend avoiding application to the nipple area and washing treated areas before nursing.
Pediatric use: Permethrin is approved for use in infants as young as 2 months of age for scabies treatment. For lice, it is approved in children over 2 months. Use caution in neonates due to immature skin barrier and metabolic pathways.
Eye exposure: Avoid contact with eyes and mucous membranes. If contact occurs, flush immediately with water.
Inflamed or raw skin: Use with caution on broken or severely inflamed skin, as absorption may be increased.
Asthma: Use with caution in patients with asthma, as rare exacerbations have been reported following exposure to pyrethroid compounds.
Drug interactions
Permethrin has minimal systemic absorption, resulting in very few clinically significant drug interactions.
Theoretical interactions:
- Esterase inhibitors: Drugs that inhibit esterases could theoretically reduce permethrin metabolism, but no clinical interactions have been documented
- Other topical agents: Concurrent use of multiple topical preparations on the same area may alter absorption or cause additive irritation
No significant interactions have been documented with:
- Systemic medications
- Other topical dermatologic agents (when applied to different areas)
- Vaccines or immunizations
Permethrin can be safely used in patients taking multiple systemic medications without dose adjustment. The lack of drug interactions is a significant advantage over oral antiparasitic agents.
Clinical pearls
Application technique for scabies: Apply 5% permethrin cream from neck down to soles of feet, including under fingernails. In infants and immunocompromised patients, also treat the scalp, face, and ears. Leave on for 8-14 hours (overnight application is typical), then wash off. Treat all household members and close contacts simultaneously.
Two-dose regimen: A second application 7-14 days after the first is often recommended to kill newly hatched mites from eggs that survived the first treatment, as permethrin may not be 100% ovicidal.
Post-treatment pruritus: Educate patients that itching may persist or even worsen for 2-4 weeks after successful treatment due to hypersensitivity to dead mite antigens. This is not treatment failure. Symptomatic treatment with antihistamines or topical corticosteroids may help.
Resistance patterns: Permethrin resistance has been reported in some geographic areas, particularly for head lice. If treatment failure occurs after proper application and re-treatment, consider alternative agents like oral ivermectin or topical malathion.
Environmental measures: Wash bedding, clothing, and towels in hot water (at least 60°C/140°F) and dry on high heat. Items that cannot be washed should be sealed in plastic bags for at least 72 hours for scabies (1-2 weeks for lice).
Crusted (Norwegian) scabies: Permethrin alone may be insufficient for crusted scabies in immunocompromised patients. Combination therapy with oral ivermectin is often required.
Lindane comparison: Permethrin has replaced lindane as first-line therapy due to superior efficacy (95% vs 80-90%), better safety profile, and lack of neurotoxicity concerns.
Pregnancy safety: Permethrin is the preferred treatment for scabies and lice during pregnancy due to minimal systemic absorption and no evidence of teratogenicity.
Practice questions
1. A 28-year-old woman presents with intense itching that is worse at night, particularly affecting the interdigital spaces, wrists, and axillae. Examination reveals erythematous papules and linear burrows. She is 12 weeks pregnant. Which of the following is the most appropriate initial treatment?
2. A 6-year-old girl was treated for head lice with permethrin 1% cream rinse one week ago. Her mother returns concerned that the child is still scratching her scalp. Examination reveals a few nits but no live lice. What is the most appropriate next step?
3. A 45-year-old HIV-positive man with a CD4 count of 50 cells/mm³ presents with widespread crusted scaly lesions on his trunk, palms, and soles, with intense pruritus. Skin scraping reveals numerous Sarcoptes scabiei mites. Which of the following is the most appropriate treatment approach?
Frequently asked questions
How does permethrin work?
Permethrin works by disrupting voltage-gated sodium channels in the nerve cell membranes of parasitic arthropods like mites and lice. This causes prolonged depolarization, repetitive nerve firing, paralysis, and eventual death of the parasite. It is highly selective for arthropod sodium channels, which explains its low toxicity to mammals. The drug also affects potassium and chloride channels in parasites, contributing to its insecticidal action.
What are the side effects of permethrin?
The most common side effects are local skin reactions including burning, stinging, itching, redness, and mild rash at the application site. Importantly, itching may persist or worsen for 2-4 weeks after treatment due to an inflammatory response to dead mite antigens, not treatment failure. Systemic side effects are rare because less than 2% is absorbed through intact skin. Allergic reactions are uncommon but can occur in patients sensitive to chrysanthemums or pyrethroid compounds.
Is permethrin safe during pregnancy?
Yes, permethrin is considered safe during pregnancy and is FDA Pregnancy Category B. Animal studies have shown no evidence of fetal harm, and the minimal systemic absorption (less than 2%) through intact skin results in very low fetal exposure. Permethrin is the preferred treatment for scabies and lice during pregnancy, replacing lindane which has neurotoxicity concerns. It can be used at any stage of pregnancy when indicated.
How long does permethrin take to work for scabies?
Permethrin kills mites rapidly upon contact, but the full clinical response takes time. The medication is applied for 8-14 hours (typically overnight) then washed off. Most mites die during this application period. However, itching may persist or worsen for 2-4 weeks after successful treatment due to hypersensitivity to dead mite antigens. A second application 7-14 days later is recommended to eliminate any newly hatched mites from eggs that survived the first treatment.
Permethrin vs lindane — what is the difference?
Permethrin is now preferred over lindane as first-line therapy for scabies due to superior efficacy (95% cure rate vs 80-90% for lindane), better safety profile, and less potential for toxicity. Lindane can cause neurotoxicity including seizures, especially with overuse or in young children, while permethrin has minimal systemic absorption and rarely causes serious adverse effects. Lindane is contraindicated in premature infants, young children, pregnant women, and patients with seizure disorders, whereas permethrin can be used safely in these populations.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: P03AC04
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.